Introduction: There are few studies on cognitive impairment in neuromyelitis optica (NMO). The purpose of this study is to assess the factors that may be related with the frequency and level of cognitive impairment in Turkish NMO patients. Methods: 22 patients with the diagnosis of NMO are evaluated retrospectively. Cognitive function was evaluated with Brief Repeatable Battery of Neuropsychological tests (BRB-N), Beck Depression Inventory (BDI) and Addenbrooke Cognitive Evaluation (ACE-R). The groups with and without cognitive impairment were compared according to age, sex, level of education, pathologic findings on cranial MRI, NMO Ig existence and EDSS score. The relation of the clinical, radiological and demographic values and patients’ depression level was evaluated. The specificity and sensitivity of ACE-R test on detecting cognitive impairment were assessed through ACE-R test results. Results: The mean age of the patients was 42.8±10.9.45.5% (n=10) of the patients had cognitive impairment and 50% (n=11) had depression. The group with cognitive impairment had significantly older age, lower educational status, higher EDSS and BDI scores (p<0.05). The mostly affected cognitive domains were memory impairment, attention and processing dysfunction. When the specificity and sensitivity of ACE-R test on NMO patients were evaluated, diagnostic level of the test was found to be statistically good since it could detect cognitive impairment with a sensitivity of 88% and specificity of 75% on a cut off level of 82.5. Conclusion: In our study, cognitive impairment and depression were detected in approximately half of the patients with BRB-N and BDI tests. It can be concluded that ACE-R test can be used to detect cognitive impairment in NMO patients. Since cognitive impairment and depression are frequent in NMO patients, it is important to assess the patients’ cognitive functions and arrange the treatments to improve their quality of life, .

How to cite: Evcili G, Yabalak A. Effects of cranial nerve blockage in patients with chronic migraine resistant to first-line treatment.

To share the data of patients who underwent carotid artery stenting (CAS) with or without a distal filtertype (DF) embolic protection device (EPD) in our clinic and our own experiences. Method: The files of patients who underwent CAS in our clinic between November 2019 and January 2021 were reviewed retrospectively. Patients with >50% stenosis in symptomatic patients, >70% in asymptomatic patients, and those who had CAS at least 48 hours after the last symptom were included. Patients who underwent acute CAS and were treated for restenosis after carotid stent or endarterectomy were excluded from the study. Thirty-five patients who used DF in CAS procedure and 16 patients who did not use EPD were included in the study. Results: No significant difference was found between the two groups in terms of new neurological and cardiac vascular events (p=0.58). A new ischemic lesion was detected in diffusion MRI in 76.5% of the patients who underwent CAS using a DF type EPD and 81.8% of patients who underwent CAS without the use of an EPD. No significant difference was found between the detection rates of new ischemic lesions (p=0.73). Conclusions: Since we found no significant difference in neurological and cardiac vascular events between the patients who underwent CAS with and without use of DF type EPD, we suggest that CAS can be performed without the use of a DF type EPD in suitable patients to reduce the cost of the procedure.

No abstract

No abstract